At its most fundamental level, the Clinical Trials Transformation Initiative (CTTI) is a group of individuals and organizations that want to improve the quality and efficiency of clinical trials. It was co-founded by Duke University and the U.S. Food and Drug Administration in 2007 in an effort to identify and address challenges to well-designed, properly executed clinical trials, and offer recommendations to improve and modernize research.
CTTI fosters an open forum for all stakeholders – 500+ organizations and approximately 80 member organizations – to discuss issues, exchange ideas, and come to a consensus on solutions. Through this unique approach of blending diverse viewpoints, our work is actionable; it helps re-shape policies and procedures across the research community to run more efficient trials, generate high-quality evidence faster and, – ultimately – improve the health of people.
